A clinical study on primary hypothyroidism and its treatment with a Unani drug.
Phase 2
- Conditions
- Health Condition 1: E039- Hypothyroidism, unspecified
- Registration Number
- CTRI/2022/04/041632
- Lead Sponsor
- Ayurvedic and Unani Tibbia College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed cases of Primary Hypothyroidism with TSH level >20mIU/L. Patient willing to participate and sign the consent form. Patient willing to discontinue the drugs taking for the treatment of Primary Hypothyroidism.
Exclusion Criteria
Patient unwilling to sign the consent form.
Patient taking hormonal therapy.
Pregnant and lactating women.
Renal and hepatic insufficiency and malignancy.
Patient with tachyarrhythmia.
Patient with increased bowel movements.
Patient with menorrhagia, metrorrhagia and polymenorrhea.
Patient with parkinsonism and tremors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TSH, Free T3 & T4 <br/ ><br>Tiredness <br/ ><br>Loss of appetite <br/ ><br>Cold intolerance <br/ ><br>Constipation <br/ ><br>Sleep <br/ ><br>will be assessed. <br/ ><br>Timepoint: 6 Week
- Secondary Outcome Measures
Name Time Method ipid Profile and Quality of Life will be assessedTimepoint: 6 Week